How has Technology Transformed Genomics Research?

Genomics research has greatly progressed over the last century, from the discovery of DNA in the late 1860s to the complete mapping of the human genome to modern-day advances such as leveraging genomics in disease control.



Recently, the field of genomics has witnessed many advances in technology that have allowed scientists to sequence genomes at an unprecedented rate and a fraction of the cost. The rich information revealed by a person’s genomic profile has incredible value in scientific research as it helps scientists develop novel therapeutics that are more effective. Here, we discuss how technology has transformed genomics research.


Many technologies have helped to further genomics research. However, arguably, ZFN, TALEN, and CRISPR-Cas9 technology have been three of the most important technologies in this field.

Zinc-finger nucleases (ZFNs) are engineered DNA-binding proteins or DNA cleavage reagents, that facilitate targeting editing by forming double-strand breaks in DNA at specific locations. ZFNs, therefore, have been developed into gene-editing tools that are useful for inducing targeted mutagenesis and carrying out targeted gene replacement at high frequencies. It is considered that the birth of ZFNs gave researchers tools with unprecedented capabilities to perform genetic manipulation.

Transcription Activator-Like Effector Nucleases (TALEN) was established in 2011. Scientists studying Xanthomonas bacteria found that the microbes were secreting effector proteins (transcription activator-like effectors, TALEs) onto the cytoplasm of plant cells, increasing their susceptibility to the bacteria. Under further investigation, the scientists discovered the action mechanisms of the effector protein were able to perform DNA binding and induce gene expression by mimicking the eukaryotic transcription factors. Instantly, it was clear that these effector proteins (TALEs) had great potential in the field of genomics.

After a few more years of work, researchers added a nuclear localization signal, half-repeat, N-terminal domain, resulting in ‘TALENs’. TALENs are artificial restriction enzymes, able to recognize specific sequences within the genome and produce double-strand breaks.

At around the same time, other groups of scientists were working on developing CRISPR-Cas9 technology, possibly the most famous genomic tool due in part to the controversial conversations it has sparked. The technology is based on two key molecules, the first is the enzyme Cas9 that acts like a pair of ‘molecular scissors’, cutting into the two strands of DNA at a predetermined location. The second is a piece of guide RNA (gRNA) that guides the enzyme to the correct part of the genomic sequence. CRISPR-Cas9 technology allows scientists to remove, add, or alter sections of the genome.

In vitro studies have already demonstrated that CRISPR-Cas9 technology has the potential to correct genetic defects such as cystic fibrosis, cataracts, and Fanconi anemia. The technology has also been used in early-stage clinical trials as a potential cancer therapy. It has also been considered as a potential tool to prevent the spread of Lyme disease, malaria, and HIV. The technology has aroused much excitement due to its potential applications across medicine and healthcare.


Image Credit: Pan Andrii/

HudsonAlpha Institute: leveraging technology in genomics research

The HudsonAlpha Institute for Biotechnology in the US is one of the global leaders in terms of genomics research. To date, work that has taken place at the institute has resulted in the development of important new therapeutics and has played a critical role in major projects including the Human Genome Project, The Cancer Genome Atlas (TCGA), and the Encyclopedia of DNA Elements (ENCODE) Project, to name a few.

Technological advancement has been at the center of HudsonAlpha’s excellence. The work undertaken at the institute is data-intensive, with significant demands in terms of data storage, manipulation, and analysis. Early on, the team at HudsonAlpha adopted cloud technology and hyper-converged infrastructure. They also leveraged composable infrastructure, which combines compute, storage, and network fabric into one resource. This amalgamation of hyper-converged and composable infrastructure has reduced the re-provisioning time from four days to under two hours as well as reduced costs.

Speed is important in research, it allows scientists to speed up the methodology and analysis and arrive at the conclusion. In genomics research, this means that scientists are able to generate genomic profiles faster, which contributes to speeding up the process of developing new therapeutics based on this research.

Genomics research and COVID-19

Genomic sequencing played an important role in controlling the COVID-19 pandemic. It allowed researchers to quickly understand the virus, how it spread, and how it affected the body. This helped us to develop preventative strategies and establish vaccines. Without genomics, the rapid roll-out of vaccination programs that was observed globally would not have been possible. The pandemic highlighted the importance of genomics, and it will likely dictate how genomics technology moves forward.

There is now a focus on preparing for the emergence of the next pathogen with pandemic potential. Rapid screening programs and testing will be essential to pandemic strategies going forward, and genomics technology will likely develop to enhance that in any way possible.


Further Reading

Last Updated: Feb 25, 2022

Sarah Moore

Written by

Sarah Moore

After studying Psychology and then Neuroscience, Sarah quickly found her enjoyment for researching and writing research papers; turning to a passion to connect ideas with people through writing.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Moore, Sarah. (2022, February 25). How has Technology Transformed Genomics Research?. AZoLifeSciences. Retrieved on April 17, 2024 from

  • MLA

    Moore, Sarah. "How has Technology Transformed Genomics Research?". AZoLifeSciences. 17 April 2024. <>.

  • Chicago

    Moore, Sarah. "How has Technology Transformed Genomics Research?". AZoLifeSciences. (accessed April 17, 2024).

  • Harvard

    Moore, Sarah. 2022. How has Technology Transformed Genomics Research?. AZoLifeSciences, viewed 17 April 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.